MP488DAILY EXIT-SITE AND INTRANASAL MUPIROCIN IN ALL PD PATIENTS TO PREVENT STAPHYLOCOCCUS AUREUS PERITONITIS: A MORE EFFECTIVE APPROACH THAN MONTHLY INTRANASAL MUPIROCIN IN STAPHYLOCOCCUS AUREUS CARRIERS ONLY

2016 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map